Site last updated:
December 2011
Cancer Services Forum currently has 1452 registered members
Cancer Services Forum is a publication aimed at PCO commissioners and their teams, cancer network management teams, service managers in cancer centres and cancer units, clinicians, pharmacists, nurses and other cancer care professionals.
The pace of change in the planning, commissioning and delivery of UK cancer services can be overwhelming — the aim of Cancer Services Forum is to communicate expert opinion on the implications of cancer policy and service initiatives on a regular basis, frequently and in a timely fashion.
Upcoming Events
Latest
Commissioning cancer care: report from the 2011 London Cancer New Drugs Group annual conference
0 comment on this article -
Be the first to comment
Welcome to the December 2011 issue of Cancer Services Forum.
The relevance of the London Cancer New Drugs Group (LCNDG) annual conference is validated by the high demand for places to attend the 2011 annual conference, the fifth such meeting. Registration was closed in August, confirming the popularity among clinicians, pharmacists, nurses, commissioners and other healthcare professionals. Although driven by the aims to facilitate consistency of approach in London by informing the managed entry of new drugs in cancer treatment and to promote the cost-effective and equitable provision of all medicines used in cancer, the topics discussed have relevance across the UK.
Equality in access to cancer treatment: a crossroad in UK cancer services?
0 comment on this article -
Be the first to comment
Welcome to the October 2011 issue of Cancer Services Forum.
This month’s issue features an update on key points of interest in cancer services written by Succinct Healthcare Communication’s own Carolyn Staines. The update looks at The Lancet Oncology Commission‘s report, Delivering affordable cancer care in high-income countries, which considers the major problems concerning all those involved with the planning, delivering, receiving and paying for cancer care in the UK.
QIPP: the cancer drugs perspective
0 comment on this article -
Be the first to comment
Welcome to the August 2011 issue of Cancer Services Forum.
This month we feature an article on QIPP—Quality, Innovation, Productivity and Prevention—written by Richard Hancox, Chief Operating Officer at Nuneaton and Bedworth Clinical Commissioning Group. Richard looks at QIPP from the perspective of cancer drugs prescribing, and considers how the QIPP agenda is being used to address the current financial problems affecting the NHS.
